{
  "background_dashed": [
    {
      "x": "School-age (6-12yo)",
      "y": "Acceptability",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 14.5,
      "Outcome_group": "Safety",
      "customLabel": "In School-age (6-12 years old),  participants, there is a small-to-moderate effect in favor of MELAT on Acceptability. Based on the analysis of the quality of the evidence produced by the 4 clinical trials exploring this effect, we have a very low confidence in the estimation of this effect."
    },
    {
      "x": "School-age (6-12yo)",
      "y": "Adverse events",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 14.5,
      "Outcome_group": "Safety",
      "customLabel": "In School-age (6-12 years old),  participants, there is no difference between MELAT and controls on Adverse events. Based on the analysis of the quality of the evidence produced by the 2 clinical trials exploring this effect, we have a very low confidence in the estimation of this effect."
    },
    {
      "x": "School-age (6-12yo)",
      "y": "Tolerability",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 14.5,
      "Outcome_group": "Safety",
      "customLabel": "In School-age (6-12 years old),  participants, there is no difference between MELAT and controls on Tolerability. Based on the analysis of the quality of the evidence produced by the 4 clinical trials exploring this effect, we have a very low confidence in the estimation of this effect."
    },
    {
      "x": "School-age (6-12yo)",
      "y": "ADHD symptoms",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 14.5,
      "Outcome_group": "Psych. comorbidity",
      "customLabel": "In School-age (6-12 years old),  participants, there is no difference between MELAT and controls on ADHD symptoms. Based on the analysis of the quality of the evidence produced by the 2 clinical trials exploring this effect, we have a very low confidence in the estimation of this effect."
    },
    {
      "x": "School-age (6-12yo)",
      "y": "Sleep quality",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 14.5,
      "Outcome_group": "Sleep",
      "customLabel": "In School-age (6-12 years old),  participants, there is a very strong effect in favor of  MELAT on Sleep quality. Based on the analysis of the quality of the evidence produced by the 5 clinical trials exploring this effect, we have a very low confidence in the estimation of this effect."
    },
    {
      "x": "School-age (6-12yo)",
      "y": "Sleep quantity",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 14.5,
      "Outcome_group": "Sleep",
      "customLabel": "In School-age (6-12 years old),  participants, there is a very strong effect in favor of  MELAT on Sleep quantity. Based on the analysis of the quality of the evidence produced by the 5 clinical trials exploring this effect, we have a very low confidence in the estimation of this effect."
    },
    {
      "x": "School-age (6-12yo)",
      "y": "Disruptive behaviors",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 14.5,
      "Outcome_group": "ASD-related symptoms",
      "customLabel": "In School-age (6-12 years old),  participants, there is no difference between MELAT and controls on Disruptive behaviors. Based on the analysis of the quality of the evidence produced by the 2 clinical trials exploring this effect, we have a very low confidence in the estimation of this effect."
    }
  ],
  "background": [
    {
      "x": "School-age (6-12yo)",
      "y": "Acceptability",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 14.5,
      "Outcome_group": "Safety",
      "customLabel": "In School-age (6-12 years old),  participants, there is a small-to-moderate effect in favor of MELAT on Acceptability. Based on the analysis of the quality of the evidence produced by the 4 clinical trials exploring this effect, we have a very low confidence in the estimation of this effect."
    },
    {
      "x": "School-age (6-12yo)",
      "y": "Adverse events",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 14.5,
      "Outcome_group": "Safety",
      "customLabel": "In School-age (6-12 years old),  participants, there is no difference between MELAT and controls on Adverse events. Based on the analysis of the quality of the evidence produced by the 2 clinical trials exploring this effect, we have a very low confidence in the estimation of this effect."
    },
    {
      "x": "School-age (6-12yo)",
      "y": "Tolerability",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 14.5,
      "Outcome_group": "Safety",
      "customLabel": "In School-age (6-12 years old),  participants, there is no difference between MELAT and controls on Tolerability. Based on the analysis of the quality of the evidence produced by the 4 clinical trials exploring this effect, we have a very low confidence in the estimation of this effect."
    },
    {
      "x": "School-age (6-12yo)",
      "y": "ADHD symptoms",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 14.5,
      "Outcome_group": "Psych. comorbidity",
      "customLabel": "In School-age (6-12 years old),  participants, there is no difference between MELAT and controls on ADHD symptoms. Based on the analysis of the quality of the evidence produced by the 2 clinical trials exploring this effect, we have a very low confidence in the estimation of this effect."
    },
    {
      "x": "School-age (6-12yo)",
      "y": "Sleep quality",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 14.5,
      "Outcome_group": "Sleep",
      "customLabel": "In School-age (6-12 years old),  participants, there is a very strong effect in favor of  MELAT on Sleep quality. Based on the analysis of the quality of the evidence produced by the 5 clinical trials exploring this effect, we have a very low confidence in the estimation of this effect."
    },
    {
      "x": "School-age (6-12yo)",
      "y": "Sleep quantity",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 14.5,
      "Outcome_group": "Sleep",
      "customLabel": "In School-age (6-12 years old),  participants, there is a very strong effect in favor of  MELAT on Sleep quantity. Based on the analysis of the quality of the evidence produced by the 5 clinical trials exploring this effect, we have a very low confidence in the estimation of this effect."
    },
    {
      "x": "School-age (6-12yo)",
      "y": "Disruptive behaviors",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 14.5,
      "Outcome_group": "ASD-related symptoms",
      "customLabel": "In School-age (6-12 years old),  participants, there is no difference between MELAT and controls on Disruptive behaviors. Based on the analysis of the quality of the evidence produced by the 2 clinical trials exploring this effect, we have a very low confidence in the estimation of this effect."
    }
  ],
  "main": [
    {
      "x": "School-age (6-12yo)",
      "y": "Acceptability",
      "r": 11,
      "backgroundColor": "#A2CDAE",
      "borderWidth": 0,
      "Outcome_group": "Safety"
    },
    {
      "x": "School-age (6-12yo)",
      "y": "Adverse events",
      "r": 8,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Safety"
    },
    {
      "x": "School-age (6-12yo)",
      "y": "Tolerability",
      "r": 11,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Safety"
    },
    {
      "x": "School-age (6-12yo)",
      "y": "ADHD symptoms",
      "r": 8,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Psych. comorbidity"
    },
    {
      "x": "School-age (6-12yo)",
      "y": "Sleep quality",
      "r": 12.5,
      "backgroundColor": "#30CC5C",
      "borderWidth": 0,
      "Outcome_group": "Sleep"
    },
    {
      "x": "School-age (6-12yo)",
      "y": "Sleep quantity",
      "r": 12.5,
      "backgroundColor": "#30CC5C",
      "borderWidth": 0,
      "Outcome_group": "Sleep"
    },
    {
      "x": "School-age (6-12yo)",
      "y": "Disruptive behaviors",
      "r": 8,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "ASD-related symptoms"
    }
  ],
  "star": [
    {
      "x": "School-age (6-12yo)",
      "y": "Sleep quality",
      "backgroundColor": "red",
      "borderColor": "#red",
      "r": 17.5,
      "pointRadius": 12.5,
      "Outcome_group": "Sleep"
    },
    {
      "x": "School-age (6-12yo)",
      "y": "Sleep quantity",
      "backgroundColor": "red",
      "borderColor": "#red",
      "r": 17.5,
      "pointRadius": 12.5,
      "Outcome_group": "Sleep"
    }
  ],
  "xLabels": ["Pre-school (<6yo)", "School-age (6-12yo)", "Adolescents (13-19yo)", "Adults (>=20yo)"],
  "yLabels": ["Overall ASD symptoms", "Social-communication", "Restricted/repetitive behaviors", "Sensory Profile", "", "Acceptability", "Tolerability", "Adverse events", "", "Global cognition (IQ)", "Adaptive behaviors", "Quality of life", "Language (Overall skills)", "Language (Expressive skills)", "Language (Receptive skills)", "", "ADHD symptoms", "Anxiety", "Mood related symptoms", "", "Disruptive behaviors", "Sleep quality", "Sleep quantity"]
}
